Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025
Summary
The Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 (HR5199) has been introduced in the House and referred to two committees. This bill aims to expand independent practice authority for PAs and NPs in rural facilities, which could reduce operational costs for healthcare providers and insurers starting January 1, 2027, if enacted. The bill does not specify any direct funding amounts.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR5199 aims to expand independent practice authority for PAs and NPs in rural healthcare settings, potentially reducing operational costs for providers and insurers.
- 2.The bill is in the early stages of the legislative process, having been introduced in the House and referred to two committees.
- 3.No direct funding is authorized or appropriated by this bill; its impact is regulatory, effective January 1, 2027, if enacted.
- 4.Healthcare providers and insurers, including $UNH, $HCA, $CNC, and $CI, are structural beneficiaries of potential cost efficiencies.
Market Implications
The Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, if enacted, is expected to benefit healthcare providers and insurers by reducing operational costs and increasing service capacity in rural areas. Companies such as UnitedHealth Group ($UNH), HCA Healthcare, Inc. ($HCA), Centene Corporation ($CNC), and The Cigna Group ($CI) could see improved margins from the effective date of January 1, 2027. However, the bill is currently in the early committee stage, and its passage is not certain. Recent market performance for these companies shows short-term gains over the last 7 days, with $UNH up 7.48%, $HCA up 3.44%, $CNC up 11.32%, and $CI up 6.82%. These movements are not linked to HR5199, which has no immediate market impact due to its legislative status and future effective date.
Full Analysis
Market Impact Score
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
SCREENS for Cancer Act of 2025
Association Health Plans Act
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $895M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $929M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $820M Department of Veterans Affairs Contract
Access to Breast Cancer Diagnosis Act of 2025
Living Donor Protection Act of 2025
SUPPORT for Patients and Communities Reauthorization Act of 2025
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Medical Treatments for Serious Mental Illness
This executive order directs the FDA to prioritize review and facilitate 'Right to Try' access for psychedelic drugs, including ibogaine compounds, that have received Breakthrough Therapy designation for serious mental illnesses. It also allocates $50 million from HHS to support state programs advancing these treatments and mandates collaboration between HHS, FDA, VA, and the private sector to increase clinical trial participation and data sharing for these drugs. The Attorney General is further directed to expedite rescheduling reviews for approved Schedule I psychedelic substances.